Mergers And Acquisitions In The Diabetes Market Share

Statistics for the 2023 & 2024 Mergers And Acquisitions In The Diabetes market share, created by Mordor Intelligence™ Industry Reports. Mergers And Acquisitions In The Diabetes share report includes a market forecast to 2030 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Mergers and Acquisitions (M&A) in the Diabetes Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Mergers And Acquisitions In The Diabetes Industry Overview

Some prominent players in the market are Medtronic, Eli Lily, Sanofi, Dexcom, and Novo Nordisk, among others. Mergers and acquisitions between players in the recent past helped companies strengthen their market presence and develop capabilities that are novel to the companies. For instance, in July 2021, Eli Lily and Company announced the acquisition of Protomer Technologies Inc. to focus on advancing glucose-responsive insulins and accelerate the development of next-generation protein therapeutics.

Mergers And Acquisitions In The Diabetes Market Leaders

  1. Eli Lily and Company

  2. Sanofi Aventis

  3. Dexcom

  4. Novo Nordisk

  5. Medtronic

  6. *Disclaimer: Major Players sorted in no particular order
Mergers And Acquisitions In The Diabetes Market Concentration

Mergers And Acquisitions In The Diabetes Market Report Snapshots